Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-61,700
Closed -$1.05M 1392
2017
Q2
$1.05M Buy
+61,700
New +$1.07M ﹤0.01% 924
2016
Q4
Sell
-7,000
Closed -$293K 1315
2016
Q3
$293K Sell
7,000
-4,600
-40% -$206K ﹤0.01% 1101
2016
Q2
$525K Sell
11,600
-11,100
-49% -$501K ﹤0.01% 998
2016
Q1
$1.13M Sell
22,700
-27,120
-54% -$1.24M 0.01% 846
2015
Q4
$2.25M Buy
49,820
+37,270
+297% +$1.74M 0.01% 748
2015
Q3
$569K Sell
12,550
-45,150
-78% -$1.98M ﹤0.01% 1017
2015
Q2
$2.74M Buy
+57,700
New +$2.75M 0.01% 726
2014
Q2
Sell
-5,800
Closed -$261K 1465
2014
Q1
$261K Hold
5,800
﹤0.01% 1182
2013
Q4
$264K Buy
+5,800
New +$251K ﹤0.01% 1177

Other funds holding SYNT

Axa's SYNT Position: Q3 2017 in Review

Axa sold out of Syntel Inc (SYNT) in Q3 2017, closing a stake of 61,700 shares — an estimated $1.05M sold.

Axa first reported a position in SYNT in Q4 2013 and held it in 9 quarters. The position peaked at $2.74M in Q2 2015. 142 funds tracked by Wall St. Rank hold SYNT as of Q3 2017.

  • Axa reported no remaining Syntel Inc position as of Q3 2017 after selling out during the quarter.
  • Axa sold 61,700 Syntel Inc shares in Q3 2017, an estimated $1.05M.
  • Axa first reported a position in Syntel Inc in Q4 2013 and held it in 9 quarters.
  • Axa's Syntel Inc position peaked at $2.74M in Q2 2015.
  • 142 funds tracked by Wall St. Rank held Syntel Inc as of Q3 2017.

Based on Axa's 13F filing for Q3 2017, filed 13 Nov 2017.